Skip to content
TrackPodcasts
businessJul 26, 202341:17pending

AI and Ozempic: The two great disruptive technologies of 2023

About this episode

AI is poised to upend the music industry, and Fast Company Associate Editor David Salazar joins us to discuss what AI generative music is and how the music industry is combating it. Antidiabetic medication Ozempic is all over the news these days, but it's not as new as it seems. Beyond the TikTok trends and celebrity shout-outs, it's been used to treat diabetes for years. But now talk of this medication has reached a fever pitch. Found CEO Sarah Jones Simmer talks about how her company prioritizes comprehensive weight care management, the ongoing discussion about Ozempic, and the very complicated history of weight in this country. Basically, how do we thread the needle between self-acceptance and positive body image and the existing health challenges, like the skyrocketing rates of diabetes? Then we discuss Barbenheimer because, well, we have to.

Get every episode summarized

Each time Most Innovative Companies publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

AI and Ozempic: The two great disruptive technologies of 2023

Most Innovative Companies

0:00
41:17

More episodes

More from Most Innovative Companies

View all episodes →